Scientists at Technion-Israel Institute of Technology Release New Data on ... Equities.com Our news editors obtained a quote from the research from the Technion-Israel Institute of Technology, "Here, we utilize gold nanospheres conjugated to Rituximab, an anti-CD20 monoclonal antibody-based drug, for carrying and releasing the drug upon ... |
